- Home
- ANEB vs FBIO Comparison
ANEB vs FBIO Comparison
Compare ANEB & FBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANEB
- FBIO
- Stock Information
- Founded
- ANEB 2020
- FBIO 2006
- Country
- ANEB United States
- FBIO United States
- Employees
- ANEB N/A
- FBIO N/A
- Industry
- ANEB Biotechnology: Pharmaceutical Preparations
- FBIO Biotechnology: Pharmaceutical Preparations
- Sector
- ANEB Health Care
- FBIO Health Care
- Exchange
- ANEB Nasdaq
- FBIO Nasdaq
- Market Cap
- ANEB 98.6M
- FBIO 88.7M
- IPO Year
- ANEB 2021
- FBIO N/A
- Fundamental
- Price
- ANEB $2.28
- FBIO $3.02
- Analyst Decision
- ANEB Buy
- FBIO Strong Buy
- Analyst Count
- ANEB 2
- FBIO 2
- Target Price
- ANEB $8.00
- FBIO $16.50
- AVG Volume (30 Days)
- ANEB 124.0K
- FBIO 1.6M
- Earning Date
- ANEB 11-12-2025
- FBIO 11-13-2025
- Dividend Yield
- ANEB N/A
- FBIO N/A
- EPS Growth
- ANEB N/A
- FBIO N/A
- EPS
- ANEB N/A
- FBIO N/A
- Revenue
- ANEB N/A
- FBIO $59,301,000.00
- Revenue This Year
- ANEB N/A
- FBIO $49.84
- Revenue Next Year
- ANEB N/A
- FBIO $42.47
- P/E Ratio
- ANEB N/A
- FBIO N/A
- Revenue Growth
- ANEB N/A
- FBIO N/A
- 52 Week Low
- ANEB $0.80
- FBIO $1.33
- 52 Week High
- ANEB $3.42
- FBIO $4.20
- Technical
- Relative Strength Index (RSI)
- ANEB 42.33
- FBIO 45.83
- Support Level
- ANEB $2.34
- FBIO $2.72
- Resistance Level
- ANEB $2.47
- FBIO $4.01
- Average True Range (ATR)
- ANEB 0.12
- FBIO 0.30
- MACD
- ANEB -0.02
- FBIO -0.11
- Stochastic Oscillator
- ANEB 13.49
- FBIO 23.57
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing treatments for cannabinoid overdose and substance addiction. Its principal product candidate, ANEB-001 (Selonabant), is designed to rapidly counteract the negative effects of cannabis toxicity, including unintentional cannabis poisoning and acute cannabinoid intoxication. The company is focusing on addressing the unmet medical needs in the treatment of cannabinoid toxicity through various therapies.
About FBIO Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.